Technology · 1 sources covering this

New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent

The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

1 L · 0 C · 0 R

How 1 sources are covering this

WIREDLean L·1h ago
New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent
The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.
Read at WIRED →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/a12526314fc5ee0f97e316ff7267bf3b64a18891"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent"></iframe>

New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent

How 1 sources are covering this

New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent

More from Technology

How to improve your PC's airflow for better cooling

AI Boom Brings New Business to Matchmakers

How long is too long for an HDMI cable?

'Father of the PlayStation' Ken Kutaragi sides with Sony on the physical discs debate

Reader

Trust & legal

Across the network